Q4 2025 Financial Overview Important Information Regarding Forward-Looking Statements: This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not ...

Core Viewpoint - Zinzino is expanding its operations into Peru, marking a significant step in its global growth strategy, with the launch scheduled for February 10, 2026 [1] Group 1: Expansion Details - The company has generated monthly sales of approximately SEK 1.5 million through its global web shop in Peru [1] - This expansion builds on Zinzino's established success in other Latin American markets, creating strong cross-border synergies for partners and customers [1] - Peru is seen as an attractive market for direct selling due to its growing entrepreneurial culture and increasing demand for flexible income opportunities [1] Group 2: Market Potential - There is a rising consumer interest in health, preventive care, and personalized nutrition solutions in Peru, supporting long-term market potential for Zinzino's science-based concept [1] - The CEO of Zinzino, Dag Bergheim Pettersen, emphasizes the strong potential for Peruvian partners to achieve long-term success with the company's test-based concept [1] Group 3: Operational Support - The launch will allow Zinzino's Independent Partners to utilize the company's existing regional infrastructure and experience for local business development [1] - Zinzino's digital platform and business model align well with the expanding digital commerce landscape in Peru, where community-driven sales are significant [1] - Customer and partner support will be coordinated by the Latin American team, with assistance from the local country manager and regional sales management [1]

Core Insights - Natural Health Trends Corp. reported a 3% sequential increase in revenue for Q4 2025 despite a challenging macroeconomic environment, while full-year net sales decreased by 10% year over year [4][6][7] - The company has completed major restructuring initiatives aimed at achieving $1.5 million in annualized cost savings and has relocated 40% of its product sourcing to East Asia to mitigate tariff uncertainties [4][6] - The company declared a quarterly cash dividend of $0.10 per share, payable on February 27, 2026 [9] Fourth Quarter 2025 Financial Highlights - Revenue for Q4 2025 was $9.7 million, a 3% increase from $9.5 million in Q3 2025 but a 10% decline from $10.8 million in Q4 2024 [7] - Operating loss for Q4 2025 was $635,000, compared to losses of $495,000 in Q3 2025 and $421,000 in Q4 2024; excluding restructuring charges, the operating loss would have been $352,000 [7] - Net loss for Q4 2025 was $588,000, or $0.05 per diluted share, compared to a net loss of $431,000, or $0.04 per diluted share, in Q3 2025 and net income of $176,000, or $0.02 per diluted share, in Q4 2024 [7] Full Year 2025 Financial Highlights - Total revenue for 2025 was $39.8 million, down 7% from $43.0 million in 2024 [7] - The operating loss for the full year was $1.8 million, compared to a loss of $1.3 million in 2024 [7] - The net loss for 2025 was $882,000, or $0.08 per diluted share, compared to net income of $572,000, or $0.05 per diluted share, in 2024 [7] Balance Sheet and Cash Flow - As of December 31, 2025, total cash, cash equivalents, and marketable securities were $28.9 million, down from $32.0 million as of September 30, 2025 [8] - Net cash used in operating activities was $959,000 in Q4 2025, compared to net cash provided by operating activities of $88,000 in Q4 2024; total cash used in operating activities for 2025 was $6.0 million, up from $3.4 million in 2024 [8] - The company has fully paid the tax liability arising from the 2017 U.S. Tax Cuts and Jobs Act [8] Management Commentary - The President of Natural Health Trends Corp. highlighted the company's 25th Anniversary in 2026 as a significant milestone, with plans for a celebration in Hong Kong [4][5] - The company aims to leverage this anniversary to create renewed momentum in its business [5]

Core Viewpoint - Natural Health Trends Corp. will report its financial results for Q4 and the full year 2025 on February 4, 2026, with a conference call scheduled for the same day to discuss these results [1][2]. Group 1: Financial Reporting - The financial results for the fourth quarter and full year ended December 31, 2025, will be announced on February 4, 2026, at 9:00 a.m. Eastern Time [1]. - A conference call to discuss the financial results will take place on the same day at 11:30 a.m. Eastern Time [1][2]. - The dial-in number for the conference call is 1-800-330-6730, and the participant ID is 992974 [2]. Group 2: Company Overview - Natural Health Trends Corp. is a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and "quality of life" products under the NHT Global brand [1][3]. - The company operates internationally through subsidiaries in Asia, the Americas, and Europe [3]. - Additional information about the company can be found on its website [3].

Core Insights - Betterware de México, S.A.P.I. de C.V. (NYSE: BWMX) has entered into a definitive agreement to acquire Tupperware's operating assets in Latin America, which includes a 100% acquisition of Tupperware's Latin American businesses and an exclusive license for the Tupperware® brand in the region [1][2] Financial Details - The acquisition is valued at $250 million, comprising $215 million in cash funded through debt and $35 million in BeFra shares, structured on a debt-free, excess-cash-free basis [2] Market Impact - This transaction will consolidate three leading brands in Latin America's direct selling market: Betterware, Jafra, and Tupperware, enhancing their market presence [2] Transaction Timeline - The deal is expected to close in the first half of 2026, pending customary regulatory and closing conditions [2] Legal Representation - The acquisition is represented by Greenberg Traurig, P.A., with a team led by Antonio Peña and includes various shareholders and associates specializing in corporate, intellectual property, and antitrust law [3][4]

Core Viewpoint - Betterware is acquiring Tupperware's Latin American operations for $250 million, which is significantly below the market average valuation multiple, indicating a strong investment opportunity [1][4][17] Acquisition Details - The acquisition price consists of $215 million in cash and $35 million in stock, representing a valuation multiple of 3.1x estimated 2025 EV/EBITDA [1][4] - The deal is expected to be immediately accretive, with projections indicating a 40% increase in earnings per share (EPS) and an annual EBITDA contribution of $81 million [6][8] Market Reaction - Following the announcement, Betterware's stock surged by over 12%, reflecting investor confidence in the acquisition's potential [5][18] - Analysts have adjusted their price targets upward, with some firms eyeing a target of $30 per share [18] Operational Strategy - Betterware plans to utilize underutilized manufacturing facilities in Mexico and Brazil, which are currently operating at 65% and 50% capacity, respectively [9][10] - The strategy involves moving production into these facilities to reduce costs and increase profit margins through better absorption of fixed costs [11] Management and Integration - Luis Campos, the current Chairman of Betterware, has a strong background in the industry, having previously served as Chairman of Tupperware Americas, which reduces integration risk [12][13] - The management has assured that the acquisition will not impact the current high-yield dividend policy, which ranges from 5% to 8% [16] Financial Health - Betterware will fund the acquisition with debt, increasing its leverage ratio from 1.6x to approximately 1.9x, which remains within a safe range [14][15] - The strong cash flow generated from the acquired assets supports the company's ability to manage this increased leverage [15]

Financial Data and Key Metrics Changes - LifeVantage has a market cap of approximately $80 million and has been publicly traded for over 15 years on Nasdaq [2][39] - The company has maintained a profitable model generating significant free cash flow, focusing on internal reinvestment and share repurchase programs [62] Business Line Data and Key Metrics Changes - The flagship product, Protandim Nrf2, remains a significant revenue driver, representing over 50% of total revenue [15][52] - The company has launched new products, including a collagen product and a GLP-1 product, which have opened new market opportunities [5][16] Market Data and Key Metrics Changes - The gut health market is projected to grow from $8 billion to $32 billion over the next eight years, indicating a compound annual growth rate (CAGR) of nearly 10% [15][52] - LifeVantage has expanded into new markets, including Iceland and the Canary Islands, leveraging existing consultant networks [67] Company Strategy and Development Direction - The company emphasizes an "activation" philosophy, differentiating its products from traditional supplementation by focusing on enhancing the body's natural production capabilities [4][44] - LifeVantage's strategy includes exploring acquisitions, as evidenced by the recent acquisition of LoveBiome, which aligns with the company's focus on gut health [46][48] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the integration of LoveBiome and noted a high retention rate of consultants post-acquisition, indicating successful integration [51] - The company aims to expand its customer base beyond the traditional anti-aging demographic by launching products that appeal to younger consumers [53] Other Important Information - LifeVantage operates in about 20 countries, with North America accounting for 78% of its revenue [21][58] - The company has optimized its compensation plan to attract micro-influencers and adapt to changes in consumer buying behavior accelerated by COVID-19 [22][59] Q&A Session Summary Question: What is the company's view on the gut health market opportunity? - The gut health market is expected to grow significantly, and the company sees it as a new area of opportunity that complements its existing product lines [15][52] Question: How has the acquisition of LoveBiome been integrated into the company? - The acquisition was completed quickly, and the integration has been successful, with high retention rates of consultants and positive cross-selling opportunities [51] Question: What are the company's future investment priorities? - Future investments will focus on technology, particularly in enhancing e-commerce capabilities through a partnership with Shopify [64]

Financial Data and Key Metrics Changes - LifeVantage has a market cap of approximately $80 million and has been publicly traded for over 15 years [3][42] - The company has maintained a profitable model that generates significant free cash flow, allowing for reinvestment into the business and share repurchase programs [65][66] Business Line Data and Key Metrics Changes - The Protandim NRF2 product remains a cornerstone of the company, representing over 50% of total revenue and classified as an anti-aging product [17][55] - The company has launched new products, including a collagen product and a GLP-1 product, which have opened new market segments and increased the body’s ability to produce essential substances [6][45][56] Market Data and Key Metrics Changes - The gut health market is projected to grow from $8 billion to $32 billion over the next eight years, indicating a compound annual growth rate (CAGR) of just under 10% [17][55] - LifeVantage has expanded into new markets, including Iceland and the Canary Islands, leveraging existing consultant networks to minimize entry costs [70] Company Strategy and Development Direction - The company is focusing on a product strategy centered around "activation," which distinguishes its offerings from traditional supplementation [4][46] - LifeVantage aims to diversify its customer base by launching products that appeal to younger demographics and different health concerns beyond anti-aging [56][57] - The recent acquisition of LoveBiome is seen as a strategic move to enhance product offerings in the gut microbiome space and integrate new consultants and customers [9][48] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the integration of LoveBiome and noted a high retention rate of consultants post-acquisition, indicating successful cross-selling opportunities [54] - The company is optimistic about the future growth potential in the gut health market and the overall strategy to connect various product lines through the activation philosophy [19][55] Other Important Information - LifeVantage has optimized its compensation plan to attract a broader range of independent consultants, including micro-influencers, to enhance sales and marketing efforts [62][63] - The company is committed to investing in technology, particularly through a partnership with Shopify to improve e-commerce capabilities [29][67] Q&A Session Summary Question: What is the company's view on the gut health market opportunity? - The gut health market is projected to grow significantly, and the company sees this as a new area of opportunity to expand its customer base beyond traditional anti-aging products [17][55] Question: How has the acquisition of LoveBiome been integrated into the company? - The acquisition was completed quickly, and the integration has been successful, with a high retention rate of consultants and positive cross-selling results [54][53] Question: What are the company's future investment priorities? - Future investments will focus on technology enhancements and international expansion, leveraging low-cost entry strategies in new markets [66][70]

Core Insights - LifeVantage Corporation has appointed Mike Edwards as Chief Technology Officer, bringing over 25 years of experience in technology leadership and enterprise transformation [1][2]. Company Overview - LifeVantage Corporation, listed on Nasdaq as LFVN, specializes in health and wellness products that activate optimal health processes at the cellular level [1][5]. - The company is a pioneer in nutrigenomics, focusing on how nutrition and naturally occurring compounds can unlock genetic health potential [5]. Leadership and Strategy - Mike Edwards is recognized as a strategic leader with a strong track record in translating technological innovation into measurable business impact, which is expected to accelerate LifeVantage's digital transformation [2]. - His expertise includes eCommerce, AI, CRM systems, and mobile technology, which will be critical for expanding the company's global footprint and enhancing technology solutions for independent consultants and customers [2][4]. Technology and Innovation - Edwards has previously led comprehensive transformation initiatives in eCommerce platforms, AI implementation, and customer experience enhancement, modernizing legacy systems and scaling global eCommerce infrastructure [3][2]. - The focus will be on leveraging cutting-edge technology to streamline operations and create seamless experiences for consultants and customers [4].

Core Insights - The World Federation of Direct Selling Associations (WFDSA) reports a global direct selling industry retail sales of approximately $164 billion, reflecting a growth of $675 million compared to pre-pandemic levels, with 45% of markets showing increases [1][2] - The number of independent representatives in the industry has slightly increased to 104.3 million, with 72.1% being women [1][5] - The U.S. remains the largest market, while significant growth is observed in Brazil, India, and China [2][3] Market Performance - The Asia-Pacific region holds the largest market share, driven by emerging markets like Malaysia, while the Americas experienced the most growth in 2024 [2] - The number of "billion-dollar markets" remains stable at 21, accounting for 92% of global sales [5] - Key sectors within the industry include wellness products, cosmetics, personal care, and household goods [5] Industry Dynamics - Direct selling is characterized by low start-up costs, strong community support, and high-quality products, making it an attractive option for entrepreneurs, particularly women [3] - The STATS report provides insights from 55 markets and anticipates potential factors affecting the industry in 2025, such as tariffs, global trade, technology, and rising interest in entrepreneurship [4]